These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 10806641

  • 1. Microbicide for prevention of sexually transmitted diseases using a pharmaceutical excipient.
    Neurath AR.
    AIDS Patient Care STDS; 2000 Apr; 14(4):215-9. PubMed ID: 10806641
    [Abstract] [Full Text] [Related]

  • 2. Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.
    Neurath AR, Strick N, Li YY, Lin K, Jiang S.
    Biologicals; 1999 Mar; 27(1):11-21. PubMed ID: 10441398
    [Abstract] [Full Text] [Related]

  • 3. Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120.
    Neurath AR, Strick N, Li YY, Debnath AK.
    BMC Infect Dis; 2001 Mar; 1():17. PubMed ID: 11602021
    [Abstract] [Full Text] [Related]

  • 4. Water dispersible microbicidal cellulose acetate phthalate film.
    Neurath AR, Strick N, Li YY.
    BMC Infect Dis; 2003 Nov 14; 3():27. PubMed ID: 14617380
    [Abstract] [Full Text] [Related]

  • 5. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.
    Nikolic DS, Garcia E, Piguet V.
    Expert Rev Anti Infect Ther; 2007 Feb 14; 5(1):77-88. PubMed ID: 17266456
    [Abstract] [Full Text] [Related]

  • 6. Microbicides: putting women in control.
    Forbes A.
    WORLD; 1998 Sep 14; (89):4-5. PubMed ID: 11365770
    [Abstract] [Full Text] [Related]

  • 7. "Inactive" polymer is active against sexually transmitted diseases.
    Larkin M.
    Lancet; 1999 Jul 31; 354(9176):399. PubMed ID: 10437880
    [No Abstract] [Full Text] [Related]

  • 8. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ, Hanes J, Shattock R, Cone RA, Friend DR.
    Antiviral Res; 2010 Dec 31; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [Abstract] [Full Text] [Related]

  • 9. Microbicide research and development--where to?
    Rustomjee R, Abdool Karim Q.
    HIV Clin Trials; 2001 Dec 31; 2(3):185-92. PubMed ID: 11590526
    [Abstract] [Full Text] [Related]

  • 10. Development pharmaceutics of microbicide formulations. Part II: formulation, evaluation, and challenges.
    Garg S, Tambwekar KR, Vermani K, Kandarapu R, Garg A, Waller DP, Zaneveld LJ.
    AIDS Patient Care STDS; 2003 Aug 31; 17(8):377-99. PubMed ID: 13678540
    [Abstract] [Full Text] [Related]

  • 11. Alginate microbead-encapsulated silver complexes for selective delivery of broad-spectrum silver-based microbicides.
    Damelin LH, Fernandes MA, Tiemessen CT.
    Int J Antimicrob Agents; 2015 Oct 31; 46(4):394-400. PubMed ID: 26184337
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Council calls for guidance on spermicide use.
    AIDS Alert; 1996 Mar 31; 11(3):27-30. PubMed ID: 11363240
    [Abstract] [Full Text] [Related]

  • 16. Topical microbicides. Current status and research considerations for adolescent girls.
    Rosenthal SL, Cohen SS, Stanberry LR.
    Sex Transm Dis; 1998 Aug 31; 25(7):368-77. PubMed ID: 9713918
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.